Shares of Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $1.77 and traded as high as $3.10. Medicure shares last traded at $3.10, with a volume of 11,355 shares trading hands.
Medicure Price Performance
The firm has a market capitalization of $32.68 million, a P/E ratio of -6.14 and a beta of 1.13. The firm has a 50 day moving average price of $1.82 and a 200-day moving average price of $1.15. The company has a current ratio of 0.97, a quick ratio of 0.64 and a debt-to-equity ratio of 0.02.
Medicure (OTCMKTS:MCUJF – Get Free Report) last released its earnings results on Friday, August 14th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The company had revenue of $5.36 million for the quarter, compared to the consensus estimate of $2.45 million. Medicure had a negative net margin of 23.14% and a negative return on equity of 54.55%.
Medicure Company Profile
Medicure Inc is a Canadian specialty pharmaceutical company focused on the development and commercialization of cardiovascular medicines. The company is headquartered in Winnipeg, Manitoba, and has concentrated its commercial activities on products intended for use in hospital and acute-care settings.
Medicure’s principal product is AGGRASTAT (tirofiban hydrochloride), an intravenous antiplatelet medication used in the management of certain patients with acute coronary syndrome and other cardiovascular conditions.
Further Reading
- Five stocks we like better than Medicure
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
